Used in pharmaceutical research as a building block for developing central nervous system agents, particularly in the synthesis of compounds targeting neurological disorders such as depression, anxiety, and ADHD. Its structure supports the design of novel psychoactive drugs due to its ability to interact with neurotransmitter receptors. Also employed in the development of radiolabeled derivatives for positron emission tomography (PET) imaging studies. Commonly found as an intermediate in the preparation of more complex pyrrolidine-based bioactive molecules.